Effect of 2-year Administration of CP-945,598 on Weight Loss Efficacy and Safety.

NCT00396448 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

1253

Enrollment

INDUSTRY

Sponsor class

Stopped See termination reason in detailed description.

Conditions

Obesity

Interventions

DRUG: CP-945,598 Treatment B
DRUG: CP-945,598 Treatment A
DRUG: Placebo

Sponsor

Pfizer